Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Adhesol
- Development stage
- Unknown
- Lead developer
- Instituto Biológico Argentino
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Adhesol is a topical antiseptic and disinfectant solution developed and marketed by Instituto Biológico Argentino. The formulation contains turpentine essence (esencia de trementina) and colophony resin (resina de colofonia) as its active ingredients. It is primarily utilized in wound care to create a protective barrier around the perimeter of a wound before the application of gauze or compresses. This barrier helps protect the surrounding skin and facilitates the adherence of dressings. It is classified under the ATC code D08AX as a dermatological antiseptic and is approved for use in Argentina.
- Brand names
- AdhesolADHESOL BIOL
- Other names
- Adhesol-Instituto Biológico Argentino
Beyond the preview
Go deeper on Adhesol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adhesol.